Search for: Latest AdditionsPreventionTreatmentMATRecoveryLaw Enforcement & CorrectionsLatest Additions Cathinones in the U.S. and Florida A resource by FADAA and the Florida Department of Children and Families Synthetic cathinones—particularly N,N-Dimethylpentylone (dipentylone)—are increasing in prevalence in the United States and Florida. These man-made stimulants, often misrepresented as MDMA or “Molly,” mimic drugs like cocaine and methamphetamine and pose serious health risks, including overdose and death. There has been a shift from Eutylone to N,N-Dimethylpentylone as the dominant synthetic cathinone, leading to significant increases in related deaths and occurrences, particularly in Florida from 2019 to 2023. This report contains recommendations for public health professionals to increase awareness, enhance toxicology testing, and expand harm reduction strategies. (05/21/2025) Preventing Veteran Suicide - A Landscape Analysis of Existing Programs, Their Evidence, and What the Next Generation of Programs May Look Like A resource from the RAND Corporation Preventing veteran suicide is a national priority for government, veteran advocacy groups, and the private sector. This attention has led many individuals and organizations to leverage their expertise to create, expand, or promote activities that they hope will prevent future deaths. In this report, the authors analyze current and emerging activities to prevent veteran suicide. They introduce the RAND Suicide Prevention Activity Matrix, a framework that organizes current approaches, how they complement each other, how they might change, their evidence for preventing veteran suicide, and why they might (or might not) work. This framework places 26 categories of activities in a matrix based on whom the activity targets (the veteran directly, those who regularly interact with the veteran, or social influences) and what the activity is intended to accomplish (address social conditions, promote general well-being, address mental health symptoms, provide mental health supports, and prevent suicide crises). Entities committed to preventing veteran suicide and seeking to design evidence-informed, comprehensive suicide prevention strategies will benefit from the framework and evidence reviewed in this report, in addition to the recommendations the authors developed from these data. (05/21/2025) Advising People on Using 988 Versus 911: Practical Approaches for Healthcare Providers A resource from Substance Abuse and Mental Health Services Administration (SAMHSA) This guide provides practical strategies for healthcare providers to help people understand when to use the 988 Suicide & Crisis Lifeline for behavioral health support and 911 for physical emergencies. By offering clear explanations, real-world scenarios, and addressing common concerns, providers can prepare people and their trusted networks to make informed decisions based on the urgency and nature of their needs. The guide emphasizes the distinctions between 988 and 911, aiming to reduce confusion and ensure timely, appropriate responses to both behavioral health crises and physical emergencies. Following these actionable steps will help foster better outcomes and strengthen the continuum of care. (04/22/2025) Report to Congress on the Prevention and Reduction of Underage Drinking 2024 A resource from Substance Abuse and Mental Health Services Administration (SAMHSA) The 2024 Report to Congress on the Prevention and Reduction of Underage Drinking includes national data on underage drinking patterns, the federally coordinated approach on underage drinking prevention and treatment, and information on the National Media Campaign: "Talk. They Hear You."® (04/16/2025) Guide to Long-acting Medications A resource from the National Council for Mental Wellbeing Drawing upon clinical guidance from the American Association of Community Psychiatrists and research from the National Institute for Mental Health, this guide emphasizes the importance of long-acting medications (LAMs) in treating psychotic disorders, bipolar disorder, opioid use disorder (OUD) and alcohol use disorder (AUD). The guide urges all community mental health and substance use treatment clinicians to provide LAMs as a first-line treatment option. It highlights the need for organizations to establish systems to educate staff, patients and families about the safe and effective use of LAMs. Additionally, it recommends implementing continuous quality improvement processes that lead to enhanced patient understanding and access to LAMs. (04/01/2025) Rural Recovery Innovations A resource by Substance Abuse and Mental Health Services Administration (SAMHSA) This fact sheet offers key points about the disparities and magnitude of behavioral health problems in rural communities and the challenges for service delivery in rural areas such as geographic distance and workforce shortages. This factsheet offers innovative and promising practice approaches to improve rural behavioral health, including how to provide greater access to services. (03/25/2025) Family Peer Support Services: Broadening the View A resource by Substance Abuse and Mental Health Services Administration (SAMHSA) This guided document summarizes the experiences, insights, suggestions, and concerns shared by participants in Family Peer Support: Broadening the View, a recent virtual event hosted by SAMHSA’s Office of Recovery. The goal of this event was to ensure that those with lived experience as advocates, leaders, peer support providers, and—most important—family members could share their perspectives regarding the possible expansion of family peer support services. (03/25/2025) Promoting Wellness in the Workplace A resource by Substance Abuse and Mental Health Services Administration (SAMHSA) A guidance document from the Wellness in the Workplace Summit that convened both federal and non-federal partners to review innovative approaches for identifying and creating employment opportunities for people in or seeking recovery from substance use and/or mental health conditions. The issue brief is intended for use as a guide by businesses and state and local governments to implement the identified best practices of recovery ready workplaces and wellness initiatives and includes information on what is a recovery ready workplace, where to start, case examples, and additional resources to learn more. (03/25/2025) Kahoot National Drug and Alcohol IQ Challenge A resource from the National Institutes of Health In this course, the National Institute on Drug Abuse explores drug use and addiction. These quizzes aim to help youth understand how drugs affect the developing #brain and the importance of making informed decisions about #drugs and #health. Test your knowledge today! (03/19/2025) Trend Alert: Drug Overdose Deaths Decrease in the U.S. and Florida A resource by FADAA and the Florida Department of Children and Families Drug overdoses in the U.S. have risen over the past several decades. However, a decrease in drug overdose deaths occurred in 2023. This is the first time since 2018 that drug overdose deaths have decreased. The age-adjusted rate of drug overdose deaths decreased from 32.6 per 100,000 population in 2022 to 31.3 in 2023. In Florida, age-adjusted deaths from drug overdoses decreased from 34.9 in 2022 to 30.8 in 2023. There are multiple public health interventions that assist in the reduction of drug overdose deaths. Increased access to medication assisted treatment and naloxone are both ways to help reduce overdose deaths. (03/14/2025) 2024 Annual Report Update: Patterns of and Trends in Substance Use in Florida A resource by FADAA and the Florida Department of Children and Families The 2024 Patterns of and Trends in Substance Use in Florida Annual Report Update presents updated data and information about substance use in Florida and the U.S. The report includes data from the Centers for Disease Control and Prevention (CDC), Florida Department of Health Florida Health Charts, and the Florida Medical Examiners Commission Drugs Identified in Deceased Persons by Florida Medical Examiners: 2023 Interim Report. It also includes data from the 2022 National Survey on Drug Use and Health (NSDUH), the 2024 Florida Youth Substance Abuse Survey, and Monitoring the Future. (02/07/2025) Public Health Response to Substance Use Stigma A resource from The National Association of County Health Officials (NACCHO) NACCHO, in collaboration with Dr. Lawrence Yang from Stigma Lab LLC, developed five toolkits to help local health departments assess stigma within their community. Four of the toolkits focus on a key population and include validated scales that can be used to develop a stigma assessment. An additional toolkit is available with information on data collection and analysis. This set includes: Healthcare Provider Substance Use Stigma Measures Toolkit Public Stigma of Substance Use Measures Toolkit First Responder Substance Use Stigma Measures Toolkit Substance Use Self-Stigma Measures Toolkit Assessment and Evaluation of Opioid-Related Stigma: A Guide for Local Health Departments (2/5/2025) National Guidance on Essential Specialty Substance Use Disorder Care A resource from the Substance Abuse and Mental Health Services Administration’s (SAMHSA) This guidance articulates a core or essential set of services for adults with SUD that should be available at any specialty SUD treatment facility in the United States. The intended audiences are states and payers, accreditation entities, adults and families in need of care, specialty SUD treatment facility operators/administrators, behavioral health professionals, researchers, and local governments. Currently, there is a dramatic lack of consistency in services available to adults in need of specialty SUD treatment. The goal of this guidance is for the intended audiences to use this tool to identify treatment gaps, support evidence-based planning, and improve outcomes for adults with SUD. (2/5/2025) New Toolkit to Expand Access to Lifesaving Opioid Overdose Reversal Medications A resource from the Substance Abuse and Mental Health Services Administration SAMHSA’s Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit is now available! This comprehensive resource is designed to help communities expand access to lifesaving medications like naloxone to reduce opioid overdose fatalities. The toolkit provides guidance for community leaders, public health professionals, and other partners to create effective overdose prevention and response strategies to improve local overdose reduction outcomes. (1/17/2025) 2024 Drugs of Abuse A resource from the Drug Enforcement Administration (DEA), U.S. Department of Justice Education plays a critical role in preventing substance use and misuse. Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly used and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts. Drugs of Abuse also offers a list of additional drug education and prevention resources. 2024 Drogas de Abuso Un recurso de la Drug Enforcement Administration (DEA), U.S. Department of Justice La educación juega un papel esencial en la prevención del uso y el uso indebido de sustancias. Drogas de abuso, Una guía de recursos de la DEA está diseñada para ser una fuente confiable de información sobre las drogas de uso más común y uso indebido en Estados Unidos. Esta guía completa proporciona información importante sobre los daños y las consecuencias del uso de drogas al describir los efectos en el cuerpo y la mente de una droga, su potencial de sobredosis, origen, situación legal y otros datos clave. Drogas de Abuso también ofrece una lista de recursos adicionales para la educación y prevención sobre drogas. (01/07/2025) Prevention Report to Congress on the Prevention and Reduction of Underage Drinking 2024 A resource from Substance Abuse and Mental Health Services Administration (SAMHSA) The 2024 Report to Congress on the Prevention and Reduction of Underage Drinking includes national data on underage drinking patterns, the federally coordinated approach on underage drinking prevention and treatment, and information on the National Media Campaign: "Talk. They Hear You."® (04/16/2025) Kahoot National Drug and Alcohol IQ Challenge A resource from the National Institutes of Health In this course, the National Institute on Drug Abuse explores drug use and addiction. These quizzes aim to help youth understand how drugs affect the developing #brain and the importance of making informed decisions about #drugs and #health. Test your knowledge today! (03/19/2025) New Resource: Early Recognition and Effective Treatment of Early Serious Mental Illness A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) This brochure emphasizes the crucial role of early detection and intervention in serious mental illnesses, emphasizing the need for prompt attention at the first onset of symptoms. In addition, the resource highlights the importance of youth and family engagement in early intervention services and supports. Early detection of serious mental illness and the provision of effective treatment can improve outcomes for individuals and promote long term mental health recovery. (08/19/2024) Report on Safer Social Media and Online Platform Use for Youth A resource from the Substance Abuse and Mental Health Services Administration The report provides a summary of the risks and benefits of social media on the health, safety, and privacy of young people; best practices for parents and caregivers; recommended practices for industry; a research agenda; and suggested future work, including for the federal government. (07/22/2024) The 5 Cs of Media Use A resource from the American Academy of Pediatrics Center of Excellence on Social Media and Youth Mental Health The 5 Cs of Media Use A resource from the American Academy of Pediatrics Center of Excellence on Social Media and Youth Mental Health Pediatricians and providers often need quick, simple ways to discuss digital media with families. To help, we developed The 5 Cs of Media Use. The 5 Cs is a mnemonic that can be used to talk to parents about kids and screens. They are: Child, Content, Calm, Crowding Out, and Communication. Along with this approach, we’ve created a series of five age-based handouts to give to parents at well-child visits. Based on current research and evidence, the handouts start by informing parents about their children’s developmental stages, how this influences media use, and healthy media habits to strive for at home. The 5 Cs are designed to meet kids, teens and parents where they are, build insight and communication skills, and motivate for healthy behavior change. (06/18/2024) Find a Lesson Plan or Activity for NDAFW A resource from the National Institute on Drug Abuse (NIDA) Explore NIDA's Lesson Plans and Activities page for engaging, ready-to-use materials and activities. All the lessons are aligned with national science and health education standards. (03/26/2024) Visit the new “Facts about Teen Drinking” website A resource from NIAAA The National Institute on Alcoholism and Alcohol Abuse has recently launched a new teens webpage: Facts About Teen Drinking. This resource for teens offers research-based information on underage drinking. (03/26/2024) NIAAA for Middle School A resource from the National Institute on Alcohol Abuse and Alcoholism This resource contains interactive activities to help parents, caregivers, and teachers of middle school students introduce and reinforce key messages about peer pressure, resistance skills, and other important topics related to underage drinking. NIAAA for Middle School replaces and continues the objectives of the long-standing and very popular Cool Spot website, remaining grounded in the Alcohol Misuse Prevention Study from the University of Michigan. (01/31/2024) Prevention Science Curriculum Infusion Resource Guide A resource by the Prevention Technology Transfer Center (PTTC) Network Through the collaborative efforts of the Drug Enforcement Agency and Discovery Education, Operation Prevention provides no-cost online tools for students, educators, families, and professionals on topics of substance use prevention. This Prevention Science Curriculum Infusion Resource Guide was developed to provide educators across disciplines with a variety of materials related to three broad conteeas where prevention science can inform prevention practice - epidemiology, evidence-based programs, and implementation. These resources can be infused into existing courses to enhance training in prevention science. (11/30/2023) Sharing Substance-Related Information with Youth 11-18: Integrating the best available evidence to prevent unintended harm A resource from A Division for Advancing Prevention and Treatment (ADAPT) The Sharing Substance-Related Information with Youth 11-18: Integrating the Best Available Evidence to Prevent Unintended Harm, created by the Prevention Intervention Resource Center, is designed to provide evidence-informed considerations for how to share substance-related information with youth 11-18 grounded in the science of social norms to reduce the risk of unintended harm. (11/21/2023) “Talk. They Hear You.”® Celebrates 10 Years of Preventing Underage Substance Use A resource by SAMHSA SAMHSA’s national prevention campaign helps parents and caregivers, educators, and community members get informed, be prepared, and take action to prevent underage drinking and other substance use. The campaign offers free tools: A mobile app Screen4Success ― a 10-minute online screening tool to better understand your child’s health, wellness, and well-being (and find resources to address their needs) “What Parents are Saying” podcast “Parents’ Night Out” educational session toolkits Discussion starter videos (and guides) Public Service Announcements (PSAs) ― for TV, radio, and print E-newsletter Other resources for parents and caregivers, schools, and communities, including products in Spanish (10/18/23) Partnering with Schools to Improve Youth Mental Health: A Resource for Community Mental Health and Substance Use Care Organizations. A resource by the Center of Excellence for Integrated Health Solutions (CoE-IHS) Collaboration between schools and community mental health organizations is essential to address one of our nation’s highest priorities: the youth mental health crisis. Community mental health and substance use care organizations are incredibly well positioned to create dramatic improvements in the mental wellbeing of young people in the U.S. by collaborating with schools and school systems to provide school-based health care. In this document, key considerations are presented alongside additional resource recommendations comprising a comprehensive, applicable guide for community-based readers seeking to establish or enhance partnerships with schools. These recommendations will guide readers on their journey in assessing the needs of their community’s youth and developing partnerships between schools and community mental health organizations with the key purpose of creating and sustaining accessible, equitable and lifesaving services for youth in the environment in which they spend most of their time — school. (9/22/2023) Youth Risk Behavior Survey Data Summary & Trends Report: 2011-2021 A resource of the Centers for Disease Control and Prevention (CDC) This report provides surveillance data from 2021, as well as 10-year trends from 2011 through 2021, on behaviors and experiences among high school students in the United States related to health and well-being. It includes data on behaviors and experiences for 29 variables across sexual behavior, substance use, experiences of violence, mental health, and suicidal thoughts and behaviors. Additionally, this year’s report includes data on social determinants of health, such as unstable housing, and protective factors, such as school connectedness and parental monitoring. (6/7/23) Youth Overdose Deaths in the U.S. and Florida A Resource from the FADAA and the Florida Department of Children and Families Although youth overdose rates had remained stable since 2010, they have risen in recent years. Among persons aged 14-18 years, overdoses increased from 2.36 per 100,000 population in 2019 to 4.57 per 100,000 in 2020. According to researchers, the increase in adolescent overdoses does not entirely mean that youth are using illicit drugs at higher rates than previous years. Researchers point to highly potent fentanyl being added to the drug supply as a main concern. (6/5/23) An Introduction to the Prevention Core Competencies for Prevention Professionals Professional development of the prevention workforce plays a vital role in the individual careers and the overall health of our communities. Introduction to the Prevention Core Competencies for Prevention Professionals is a new HealtheKnowledgecourse developed by SAMHSA (Substance Abuse and Mental Health Services Administration) & the PTTC National Coordinating Office, based on SAMHSA’s 2021 research report Prevention Core Competencies. The six-module course covers foundational competencies for prevention professionals and the needed knowledge, skills and abilities associated with each. The curriculum utilizes evidence-based strategies for adult learning; and builds upon and complements existing workforce training curricula and resources (e.g., Substance Abuse Prevention Specialist Training (SAPST), Foundations of Prevention Science and Practice Curriculum, and Universal Prevention Curriculum). To create an account and view the full catalog of courses, visit HealtheKnowledge.org. (6/5/23) The US Surgeon General’s Framework for Workplace Mental Health and Wellbeing A resource from the US Department of Health and Human Services (DHHS), Office of the US Surgeon General This document offers a framework to build workplaces that are engines of well-being, showing workers that they matter, that their work matters, and that they have the workplace resources and support necessary to flourish. (5/26/23) Community Engagement: An Essential Component of an Effective and Equitable Substance Use Prevention System A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) By engaging community members, prevention systems learn firsthand from individuals and community systems about substance use problems and social determinants that influence behavioral health. Community engagement brings together the skills, knowledge, and experiences of diverse groups to create and/or implement solutions that work for all members of the community. This guide focuses on how community engagement can play a critical role in the equitable scale-up of evidence-based programs and policies within the substance use prevention system. The guide presents what we know about community engagement from research studies, reporting on common community engagement activities and outcomes. It also discusses practical considerations drawn from on-the-ground experience regarding how to participate effectively in community engagement. (12/8/22) Implementing Community-Level Policies to Prevent Alcohol Misuse A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) Alcohol misuse is focused on binge and heavy drinking patterns within a community or at the population level. This guide will serve as a compendium of key policies for the prevention of alcohol misuse that have been identified as evidence-based by robust scientific literature. (11/4/22) Underage Drinking Fact Sheets - Spanish Versions A Resource from the Substance Abuse and Mental Health Administration (SAMHSA) After High School: Talking With Your Young Adult about Underage Drinking (Spanish Version) This data visualization illustrates the correlation between alcohol use and other substance use to inform parents/guardians and communities. Read More (5/20/22) Tips for Teens: The Truth about Alcohol (Spanish Version) This data visualization illustrates the drinking habits of adolescents to inform parents/guardians and communities. Read More (5/20/22) Underage Drinking Data Visualizations Tools - Spanish Versions A Resource from the Substance Abuse and Mental Health Administration (SAMHSA) These data visualizations on underage drinking have been updated with the latest statistics from SAMHSA’s 2020 National Survey on Drug Use and Health. Be Prepared to Have the Difficult Conversation (Spanish Version) This data visualization illustrates the correlation between alcohol use and other substance use to inform parents/guardians and communities. Read More (5/20/22) Getting Ahead of a Problem (Spanish Version) This data visualization illustrates the drinking habits of adolescents to inform parents/guardians and communities. Read More (5/20/22) Take Action to Prevent Underage Alcohol Use (Spanish Version) This data visualization illustrates the steady decline of alcohol use amongst adolescents, informing parents/guardians and communities that taking action against underage drinking is effective. Read More (5/20/22) Underage Drinking Data Visualizations Tools A Resource from the Substance Abuse and Mental Health Administration These data visualizations on underage drinking have been updated with the latest statistics from SAMHSA’s 2020 National Survey on Drug Use and Health. Be Prepared to Have the Difficult Conversation This data visualization illustrates the correlation between alcohol use and other substance use to inform parents/guardians and communities. Read More (1/26/21) Getting Ahead of a Problem This data visualization illustrates the drinking habits of adolescents to inform parents/guardians and communities. Read More (1/26/21) Take Action to Prevent Underage Alcohol Use This data visualization illustrates the steady decline of alcohol use amongst adolescents, informing parents/guardians and communities that taking action against underage drinking is effective. Read More (1/26/21) Prevent Unsafe Drinking Behaviors On Campus This data visualization illustrates heavy alcohol use and binge drinking statistics amongst college age youth to inform colleges and communities. Read More (1/26/21) One Pill Can Kill A Resource from the United States Drug Enforcement Administration A campaign to inform the American public of the dangers of fake prescription pills. The only safe prescription medications are ones prescribed by a trusted medical professional that you get from a licensed pharmacist. All other pills are unsafe and potentially deadly. (12/21/21) Growing Up Drug Free: A Parent’s Guide to Substance Use Prevention A Resource from the Drug Enforcement Administration This updated edition is a publication jointly produced by DEA and the U.S Department of Education. The guide includes an overview of substance use among children, youth, and young adults; descriptions of some substances young people may use; a look at risk factors that may make children, youth, and young adults try alcohol, tobacco, or other drugs, and protective factors that help offset those risks, along with suggestions for how to talk to young people about alcohol, tobacco, and other drugs. The online version of the guide is available at www.getsmartaboutdrugs.gov/publications. The U.S. Department of Education is currently working on a Spanish version of the publication, and DEA is working toward obtaining print copies for distribution. (11/18/21) Preventing Marijuana Use Among Youth A resource from the Substance Abuse and Mental Health Services Administration The goal of this guide is to review the literature on prevention of marijuana use among youth, distill the research into recommendations for practice, and provide examples of the ways these recommendations can be implemented. (11/18/21) Substance Use Trend Alert 2 - Stimulant Death Trends in the U.S. and Florida Cocaine and methamphetamine are highly addictive stimulants that have abuse potential. Increase in use over time can cause health issues and could ultimately lead to death. Cocaine and methamphetamine overdose deaths have been on the rise in the U.S. Between 2013 and 2019, deaths involving cocaine tripled in the U.S. and deaths involving methamphetamine quadrupled. Florida's rate of death involving cocaine exceeds the national rates. In Florida, there were 4.2 methamphetamine deaths per 100,000. (10/4/21) Tools for Supporting Emotional Wellbeing in Children and Youth A resource from The National Academies of Sciences, Engineering, Medicine Social distancing, disrupted routines, and a lost sense of security and safety have made some kids and teens vulnerable to stress, anxiety, and depression during the pandemic. A new set of tools from the National Academies helps kids and adults build skills to cope with stress. (9/28/21) Recursos Para Apoyar el Bienestar Emocional en Niños y Jóvenes Un recurso de The National Academies of Sciences, Engineering, Medicine El distanciamiento social, los cambios en sus rutinas y una sensación perdida de seguridad y protección, han hecho que algunos niños y adolescentes sean vulnerables al estrés, la ansiedad y la depresión durante la pandemia. Un nuevo conjunto de herramientas de las Academias Nacionales ayuda a niños y adultos a desarrollar habilidades para lidiar con el estrés. (9/28/21) Vaping Among Youth & Young Adults in the U.S. and Florida Vaping among youth and young adults has increased rapidly in recent years. In 2018, the U.S. Surgeon General declared youth vaping e-cigarettes an epidemic. In 2019, vaping prevalence rates continued to rise according to national and statewide surveys administered in Florida among youth. The harmful effects of vaping and prevention recommendations are also mentioned within this trend alert. (9/15/21) Back to School After COVID-19: Supporting Student and Staff Mental Health Toolkit The Toolkit is designed to help guide conversations to include a trauma-informed, equitable, and compassionate lens to providing mental health supports to every member of the school community. (8/30/21) Patterns of and Trends in Substance Use in Florida The annual report provides an overview of substance use trends within and across regions in Florida. The report is based on data obtained from a diverse number of sources including the National Survey on Drug Use and Health (NSDUH), the Center for Disease Control and Prevention's Behavioral Risk Factor Prevalence Surveillance System (BRFSS), and the Youth Risk Behavior Surveillance System (YRBSS). An update from the Drugs Identified in Deceased Persons by Florida Medical Examiners Interim Report for 2020 has been included. (8/30/21) Prevention Core Competencies These prevention core competencies and accompanying knowledge, skills, and abilities offer professional direction to the prevention field, affecting staff development and career ladders and pipelines, and providing guidance for training programs and service delivery qualification. (5/12/21) Facts on Underage Drinking This fact sheet offers cited facts about alcohol use among underage youth. The fact sheet covers age ranges, gender and racial trends, and alcohol use consequences. Read More (4/22/21) Underage Drinking: Myths vs. Facts This fact sheet is written specifically for preteens and teens. It compares the myths with the facts about alcohol use among youth and the effects of alcohol use. This fact sheet can help parents and prevention professionals start conversations about underage drinking and alcohol misuse. Read More (4/22/21) Facts on College Student Drinking This fact sheet offers cited facts about alcohol use among college students. The fact sheet covers age ranges, gender trends, and alcohol use consequences. Read More (4/22/21) Talk. They Hear You. Talking with Your Teen About Marijuana: Keeping Your Kids Safe—Parent Brochure By the Substance Abuse and mental Health Services Administration A brochure for parents and caregivers about the risks associated with marijuana for teens and the importance of having conversations with their children to help them avoid substance use. Read More (3/4/21) Talk. They Hear You. Talking with Your Teen About Vaping: Keeping Your Kids Safe—Parent Brochure By the Substance Abuse and mental Health Services Administration A brochure for parents and caregivers about the risks associated with vaping for teens and the importance of having conversations with their children to help them avoid substance use. Read More (3/4/21) Talk. They Hear You. 5 Conversation Goals: Talking with Teens About Alcohol and Other Drugs—Mini Brochure By the Substance Abuse and mental Health Services Administration A mini brochure for parents and caregivers on the five goals to keep in mind when having conversations about alcohol and substance use with their teens. Read More (3/4/21) Talk. They Hear You. Talking with Your Teen About Opioids: Keeping Your Kids Safe—Parent Brochure By the Substance Abuse and mental Health Services Administration A brochure for parents and caregivers about the risks associated with misusing prescription pain medications for teens and the importance of having conversations with their children to help them avoid taking medication that is not theirs. Read More (3/4/21) 2020 National Drug Threat Assessment From the US Drug Enforcement Administration The National Drug Threat Assessment provides a yearly assessment of the challenges communities face related to drug abuse and drug trafficking. The assessment gathers information from many data sources, such as drug investigations and seizures, drug purity, laboratory analysis, information on transnational and domestic criminal groups, and U.S. government drug cultivation and production estimates. Highlights in the report include usage and trafficking trends for drugs such as prescription drugs, heroin, methamphetamine, cocaine, marijuana, and hundreds of synthetic drugs. New to this year’s report is the effect of COVID-19 during the first part of 2020. (3/3/21) Polysubstance Use Trends Across the Nation and Florida Polysubstance overdose deaths are increasing in the United States and in Florida. Opioid-involved polysubstance use includes the combination of two or more substances like illicit fentanyl and heroin, illicit fentanyl and cocaine. heroin and methamphetamine, and prescription or illicit opioids and benzodiazepines. Polysubstance use has been associated with poorer recovery outcomes (i.e. poorer treatment retention, higher rates of relapse and higher mortality rates) compared to mono-substance use. Interventions tailored to address polysubstance use should be developed and implemented. (2/25/21) Mental Health, Substance Use, and Wellbeing in Higher Education: Supporting the Whole Student By The National Academies of Sciences, Engineering, and Medicine. Mental Health, Substance Use, and Wellbeing in Higher Education lays out a variety of possible strategies and approaches to meet increasing demand for mental health and substance use services, based on the available evidence on the nature of the issues and what works in various situations. The recommendations of this report will support the delivery of mental health and wellness services by the nation's institutions of higher education. (2/11/21) Alcohol Consumption Trends Across the Nation and Florida Deaths from the use of alcohol have been increasing in the United States since 1999. While alcohol consumption is a risk factor for several physical and behavioral health problems, most adults consume alcohol at least occasionally. Excessive alcohol intake, however, can negatively affect the brain, liver, and other organs. The long-term effects of excessive alcohol intake can lead to death. This Alert presents alcohol use trends for the U.S. and Florida along with helpful resources and research for the prevention of alcohol misuse. (2/9/21) Patterns and Trends of Substance Use Within and Across the Regions of Florida Annual Report 2020 This report provides a statewide and regional overview of Florida substance use patterns and trends using data from a diverse number of sources available as of May 2020. According to the analysis, the prevalence of current substance use among Florida youth continued to decline and general trends for adult substance use remained relatively flat from 2002 to 2018. While Florida fatal drug poisonings declined in 2018 for the first time since 2013, an increase in deaths due to psychostimulants was observed. Synthetic opioid deaths continue to rise and polysubstance use continues to be involved in an increasing number of poisoning deaths, particularly related to opioids and stimulants. Overall drug arrests have declined steadily throughout this period as have motor vehicle crashes, injuries and fatalities involving alcohol. (2/9/21) SAMHSA Substance Use Disorder Advisories SAMHSA has published a series of Advisories based on existing Treatment Improvement Protocols and Technical Assistance Publications. The Advisories provide a concise summary of the latest information on the topic in the substance abuse treatment field. The Advisories include: Advisory: Comprehensive Case Management for Substance Use Disorder Treatment Advisory: Using Motivational Interviewing in Substance Use Disorder Treatment Advisory: Screening and Treatment of Viral Hepatitis in People with Substance Use Disorders Advisory: Screening and Treatment of Substance Use Disorders among Adolescents Advisory: Addressing Suicidal Thoughts and Behaviors in Substance Use Treatment Advisory: Treating Substance Use Disorders Among People with HIV Advisory: Group Therapy in Substance Use Treatment Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder Advisory: The Importance of Family Therapy in Substance Use Disorder Treatment Advisory: The Substance Use Disorder Counseling Competency Framework: An Overview Advisory: Integrating Vocational Services into Substance Use Disorder Treatment (2/2/21) Supporting Children and Teens During this Holiday Season Factsheet Offers parents and caregivers strategies and ideas for supporting children and teens during the holiday season. This fact sheet provides tips that parents can use to talk to their children and teens about how they are feeling and changes to holiday celebrations and traditions. It also shares tips that families can use to make this holiday season still feel special, including creative ways in which families can stay connected to loved ones and friends. Ideas for self-care and additional resources are also included in the fact sheet. (11/16/20) 2020 Florida Youth Substance Abuse Survey (FYSAS) The Florida Department of Children and Families releases the Florida Youth Substance Abuse Survey. The FYSAS is a collaborative effort between the Florida departments of Health, Education, Children and Families, and Juvenile Justice. It is based on the "Communities That Care " survey, assessing risk and protective factors for substance abuse, in addition to substance abuse prevalence. In the spring of even years, the survey is administered simultaneously with the Florida Youth Tobacco Survey, sampling enough students to generate data applicable at the county and DCF district level. The surveys are administered to a statewide sample of students. (10/2/20) In addition to the statewide data table the county level data will be available in October. Public Perception of Mental Health and Suicide Prevention Survey Results (August 2020) National Action Alliance for Suicide Prevention In partnership with the American Foundation for Suicide Prevention, Education Development Center, and Suicide Prevention Resource Center, the Action Alliance conducted a national survey to better understand the general public's perceptions on mental health, suicide, and suicide prevention. The survey, which builds upon previous surveys in 2015 and 2018, speaks to the need for urgent action around these critical public health issues, especially in the wake of the COVID-19 pandemic. (9/3/20) Youth Risk Behavior Surveillance — United States, 2019 Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention Health risk behaviors practiced during adolescence often persist into adulthood and contribute to the leading causes of morbidity and mortality in the United States. Youth health behavior data at the national, state, territorial, tribal, and local levels help monitor the effectiveness of public health interventions designed to promote adolescent health. The Youth Risk Behavior Surveillance (YRBS) System is the largest public health surveillance system in the United States, monitoring a broad range of health-related behaviors among high school students. This report, includes a Surveillance Supplement featuring several articles written by experts from the National Center for Injury Prevention and Control using 2019 national YRBS data on the following topic areas: interpersonal violence victimization, suicidal ideation and behaviors, transportation risk behaviors, prescription opioid misuse, and trends in violence victimization and suicide risk by sexual identity. (8/20/20) CollegeAIM – the College Alcohol Intervention Matrix (Revised & Updated) The National Institute on Alcohol Abuse and Alcoholism (NIAAA), within the National Institutes of Health (NIH), recently updated their CollegeAIM – the College Alcohol Intervention Matrix. The free resource was originally developed to help college officials select effective alcohol interventions that are applicable to their student body, campus environment, and local community. The update includes seven new interventions, adding to the 60 interventions included in the first edition. CollegeAIM also provides an interactive strategy planning worksheet to help officials select a combination of approaches that meet the needs of their campus while taking into account budgetary concerns. (8/4/20) The Mind Matters series The series consists of nine booklets on various drug topics. The series was designed to help students in grades 5 through 8 understand the effects and consequences of drug use on the brain and body. The accompanying online Teacher’s Guide includes science-based information and engaging activities to enhance learning. In addition, short video clips are available to supplement the lessons. (5/4/20) Rural Community Action Guide: Building Stronger, Healthy Drug-Free Rural Communities. White House Office of National Drug Control Policy (ONDCP) Publication The purpose of the Guide is to arm rural leaders with information they can put into immediate action to create change. It provides background information, recommended action steps, and promising practices to help manage the impact of substance use disorder on local communities and help persons with the disease of addiction. The topics are based on lessons learned from Department of Agriculture rural round table discussions held in over a dozen states, as well as the experiences of several rural stakeholder partners. (2/26/20) 2019 Monitoring the Future Survey Monitoring the Future (MTF) is a long-term study of substance use and related factors among U.S. adolescents, college students, and adult high school graduates through age 60. It is conducted annually and supported by the National Institute on Drug Abuse. MTF findings identify emerging substance use problems, track substance use trends, and inform national policy and intervention strategies. The report includes a summary of the key findings regarding use of various substances by 8th, 10th, and 12th graders surveyed across the coterminous U.S. in 2019. (2/4/20) Prevention with Purpose: A Strategic Planning Guide for Preventing Drug Misuse Among College Students This guide provides a road map for university prevention professionals to collaborate with a wide range of stakeholders, from students to administrators, to address campus-wide drug misuse issues. We use the Strategic Prevention Framework (SPF) here as the “how to” for systematically measuring the scope of drug misuse issues, building relationships with key stakeholders, and planning and implementing a drug misuse prevention effort. Developed by the Substance Abuse and Mental Health Services Administration in 2004, the SPF is evidence based, widely used, and easily adaptable for multiple health issues. (1/21/20) Patterns and Trends of Substance Use Within and Across the Regions of Florida, Update This report provides a brief update to the 2019 Annual Report of the same name published in April 2019. The update is based on data released since the dissemination of the report that includes national data from the National Survey on Drug Use and Health (NSDUH), sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), and data from the 2018 interim report, Drugs Identified in Deceased Persons by Florida Medical Examiners, prepared by the Florida Medical Examiners Commission, Florida Department of Law Enforcement and published July 2019. (11/15/19) 2019 Florida Youth Substance Abuse Survey State Report The 2019 Florida Youth Substance Abuse Survey (FYSAS) Report provides information, data and trends to help guide Florida’s efforts to reduce and prevent the use of alcohol, tobacco and other drugs by school-aged youth. A collaborative effort of the Florida Departments of Children and Families, Health, Education and Juvenile Justice, the 2019 FYSAS was administered to nearly 10,000 middle and high school students from 170 schools across Florida. In its 19th year, the FYSAS provides a valuable source of information for substance use prevention and treatment planning to support Florida’s families and communities. (11/13/19) Keeping Youth Drug Free This resource guide for parents offers advice on keeping children substance free. Review statistics about adolescent substance use, and learn tips on good communication. The guide also features substance facts and case studies for additional insight. (10/1/19) Know the Risks of Meth - Resources to address meth Methamphetamine (meth) is a powerful, highly addictive drug that causes devastating health effects, and sometimes death, even on the first try. (9/23/19) Know the Risks of Marijuana Marijuana is the most commonly used illegal substance in the U.S. and its use is growing. Marijuana use among all adult age groups, both sexes, and pregnant women is going up. At the same time, the perception of how harmful marijuana use can be is declining. Increasingly, young people today do not consider marijuana use a risky behavior. (6/20/19) Substance Abuse Trends Alert: Progressive Increase in E-Cigarette Use by Age in Florida Youth Data shows that electronic cigarette use among adolescents in Florida is an emerging epidemic. Within two years the E-Cigarette usage has grown 43% among the 11-18-year-old age group. Also, gender difference has been noted with a 61% increase among the girls. (6/14/19) SAMHSA Tips for Teens Series SAMHSA's "Tips for Teens" series, specifically designed for teens, addresses the risks, statistics, and myths about various substances that teens may use. SAMHSA has released two new “Tips for Teens” and updates. (5/20/19) Tips for Teens: E-Cigarettes Tips for Teens: Marijuana Tips for Teens: Opioids Tips for Teens: Steroids Tips for Teens: Tobacco Tips for Teens: The Truth About Cocaine Tips for Teens: The Truth About Heroin Tips for Teens: The Truth About Methamphetamine Tips for Teens: The Truth About Inhalants Underage Drinking: Myths vs. Facts Substance Abuse Trends Alert: Rapid Increase in E-Cigarette Use among Florida Youth Vaping poses a considerable – and avoidable – health risk to young people. While waiting for better data on the long-term effects of “vaping” and additional regulations, it is prudent to seek paths to prevent use, especially among teens. According to The 2016 Surgeon General Report, increases in electronic cigarette use, particularly among adolescents, indicates an emerging epidemic despite significant declines in tobacco use. More than 500 brands and flavors of electronic vaping products are currently marketed while the FDA funds research in collaboration with the National Institute of Health to identify evidence-based regulations for these products. (4/24/19) Clinical Guidance for Treating Pregnant and Parenting Women This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. Patterns and Trends of Substance Abuse in Florida Within and Across the Regions of Florida The drug-by-drug review of trends, progress, and challenges addresses: underage drinking; nicotine and E-cigarettes; vaping; marijuana; novel psychoactive substances such as synthetic cannabinoids, synthetic cathinones, tryptamines, and piperazines; cocaine; methamphetamine; heroin; non-medical misuse and abuse of medications such as prescription opioids, benzodiazepines, stimulants, and over the counter (OTC) medications. (June 2017) Treatment SAMHSA Advisory: Prescription Stimulant Misuse and Prevention Among Youth and Young Adults A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse. (08/06/2024) Mental Health Client-Level Data (MH-CLD) 2022: Data on Clients Receiving Mental Health Treatment Services Through State Mental Health Agencies A resource from the Substance Abuse and Mental health Services Administration Mental Health Client-Level Data (MH-CLD) 2022: Data on Clients Receiving Mental Health Treatment Services Through State Mental Health Agencies annual report presents the total number of clients receiving mental health treatment services in 2022 by demographics, National Outcome Measures (NOMs), and the top five mental health diagnoses for children (ages 0-17) and adults (ages 18 and older) by geographic distribution, and a summary of client characteristics for the 2018-2022 reporting periods. (05/03/2024) Behavioral Health among Older Adults: Results from the 2021 and 2022 National Surveys on Drug Use and Health A resource from the Substance Abuse and Mental health Services Administration An infographic report highlighting substance use and mental health indicators among older adults aged 60 or older in the United States. This report focuses on substance use and mental health indicators among older adults aged 60 or older in the United States based on pooled National Survey on Drug Use and Health (NSDUH) data from 2021 and 2022 except where noted. Estimates are presented by gender. (05/03/2024) 2021-2022 Behavioral Health Barometers Now Available A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) Explore state and regional data with these user-friendly behavioral health reports for each of the ten HHS regions of the United States. Each report uses data from the 2021-2022 National Surveys on Drug Use and Health (NSDUH). The topics addressed in the reports include substance use, substance use disorders, and mental health. Selected estimates are provided for adolescents aged 12 to 17, underage people aged 12 to 20, adults aged 18 or older, and the general population aged 12 or older. Statistical tests compare population percentages of (1) HHS region versus national estimates, (2) state versus national estimates, and (3) state versus HHS region estimates. (04/24/2024) Mind Matters Series A resource from National Institute on Drug Abuse (NIDA) Mind Matters invites young teens to take a scientific journey to learn about the brain’s complex responses to specific drugs, including cocaine, inhalants, K2/Spice and Bath Salts, marijuana, methamphetamine, nicotine, opioids, and prescription stimulants. The Mind Matters series is a valued resource for tens of thousands of teachers. Both English and Spanish booklets, as well as the accompanying Teacher’s Guide, are all available online in printable PDFs. (03/14/2024) Mind Matters—Cosas de la mente. n recurso de National Institute on Drug Abuse (NIDA) Mind Matters—Cosas de la mente. Un recurso de National Institute on Drug Abuse (NIDA) Esta serie completa fue diseñada para alentar a los alumnos de sexto a octavo grado a aprender sobre los efectos del abuso de drogas en el cuerpo y el cerebro. (03/14/2024) New Resource: Examining the Use of Braided Funding for Substance Use Disorder Services A resource from SAMHSA This report includes innovative ways to use braided funding for substance use disorder (SUD) services to help optimize resources, improve patient outcomes, promote funding sustainability, and address service gaps. In addition, the report discusses state and federal laws and policies that encourage braided funding to provide SUD services, best practices for braiding funds, and pathways to sustainability for SUD programs. Included in the report are eight (8) case studies from state and local officials across multiple agencies, analysis of service purchasing patterns, and associated policies and laws in place driving those decisions. (03/11/2024) SAMHSA Advisory: Low Barrier Models of Care for Substance Use Disorders A resource from SAMHSA The advisory outlines recommendations for implementation of low barrier models of care to significantly expand access to lifesaving treatment for individuals with substance use disorders (SUDs). The advisory emphasizes the importance of low barrier care in overcoming substantial gaps in access to SUD treatment and engaging more people in care. Despite robust evidence showing the effectiveness of SUD treatment, fewer than 10% of individuals who need care receive it. Barriers such as lack of treatment availability, strict program requirements, stigma, and discrimination have resulted in treatment gaps, especially among marginalized communities. It describes key principles of low barrier care, including person-centeredness, harm reduction, flexibility, cultural responsiveness, and trauma-informed approaches. It also outlines essential components like same-day treatment availability, integrating services across settings, telehealth options, individualized care, and peer support. SAMHSA aims to support providers, communities, and policymakers in implementing low barrier models of care. Expanding access through low barrier approaches can improve outcomes and save lives. Accordingly, this advisory provides actionable guidance to help make patient-centered, low barrier treatment a reality. (12/11/2023) Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues Treatment Improvement Protocol (TIP) Series No. 65 A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) This Treatment Improvement Protocol (TIP) provides guidance to counselors, administrators, and supervisors about recovery-oriented services, supports, and care, allowing them to better serve individuals in or seeking recovery from problematic substance use. (11/16/2023) Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (NSDUH) A resource by SAMHSA This report provides key findings from the 2022 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment among the noninstitutionalized U.S. population aged 12 or older. Estimates are presented by age group and by race/ethnicity for selected measures. Some findings include the following results: Among the 137.4 million (or 48.7%) current alcohol users aged 12 or older in 2022, a little less than half (or 44%) were past month binge drinkers. About a quarter of people aged 12 or older (or 26%) who were binge drinkers in the past month were heavy alcohol users in 2022. In 2022, 70.3 million people aged 12 or older (or 24.9%) used illicit drugs in the past year. Marijuana was the most used illicit drug, with 22.0% of people aged 12 or older using it in the past year. In 2022, almost 1 in 4 adults aged 18 or older had any mental illness (AMI) in the past year (59.3 million or 23.1%). Among adolescents aged 12 to 17 in 2022, 19.5% (or 4.8 million people) had a past year major depressive episode (MDE). (11/15/2023) 2021 Mental Health Client-Level Data (MH-CLD) Annual Report A resource by SAMHSA SAMHSA has released the 2021 Mental Health Client-Level Data (MH-CLD) Annual Report. The annual report details the total number of clients receiving mental health treatment services in 2021 by demographics, National Outcome Measures (NOMs), and the top five mental health diagnoses for children (ages 0-17) and adults (ages 18 and older) by geographic distribution. The current MH-CLD system was developed by SAMHSA in collaboration with the Mental Health Services Block Grant recipients and launched in 2011. SAMHSA uses the MH-CLD data to enhance the understanding of publicly funded mental health treatment service systems. The data is used to inform decisions about SAMHSA’s use of its mental health block grant funds, and facilitates a better understanding of the technical assistance and support needs of mental health providers and the communities they serve. (10/18/23) Trend Alert #2—New Synthetic Cathinone in the U.S. and Florida A Resource from the FADAA and the Florida Department of Children and Families New synthetic cathinones emerge frequently in the drug market. N,N-dimethylpentylone is a recent novel psychoactive substance that is now substituted for stimulant drugs such as Ecstasy, Molly, and MDMA. Side effects include high blood pressure, rapid heart rate, and even death. The National Drug Early Warning System reports increased findings for this drug in Florida. It is important to raise awareness about the risks and dangers associated with synthetic stimulant use, provide counseling about the potential harms of use, conduct further toxicology testing, and offer education about the limited quality control of these drugs. (10/10/2023) The Substance Abuse and Mental Health Services Administration (SAMHSA) 2023-2026 Strategic Plan A resource by SAMHSA The SAMHSA’s 2023-26 strategic plan emphasizes a more person-centered approach and introduces a new mission and vision, key priorities and guiding principles. The key priorities are: Preventing Substance Use and Overdose Enhancing Access to Suicide Prevention and Mental Health Services Promoting Resilience and Emotional Health for Children, Youth and Families Integrating Behavioral and Physical Health Care Strengthening the Behavioral Health Workforce The Strategic Plan includes strategic goals and affiliated objectives associated with each key priority. It also integrates four guiding principles (equity, trauma-informed approaches, recovery, and a commitment to data and evidence) across all policies and programs to support SAMHSA in achieving its mission and vision. This plan not only represents SAMHSA’s thinking as an agency, but also reflects the insightful feedback we have received from our many stakeholders. We hope it informs and guides your planning as you work to develop and implement programs and policies that ensure people living with, affected by, or at risk for mental health and substance use conditions receive care, achieve wellbeing, and thrive. (8/22/2023) (8/22/2023) New Advisory: Digital Therapeutics for Management and Treatment in Behavioral Health A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) SAMHSA is releasing a new advisory on Digital therapeutics for management and treatment in behavioral health – This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. The advisory describes the research, regulatory, and reimbursement implications for DTx, including those by various federal agencies. The advisory outlines selection and implementation considerations for payers and providers and addresses issues related to equitable access of DTx in behavioral health. DTx meet a long-standing need in behavioral health care to improve access to services, reduce costs, and provide new treatment options for providers and clients. (7/27/2023) Access For Everyone: Addressing Health Equity and Racial Justice within Integrated Care Settings A resource from the National Council of Mental Wellbeing This free interactive toolkit provides the resources you need to help your organization address racial inequities and the associated stigmas that lead to mental health and substance use treatment disparities. Use the toolkit to expand your awareness and understanding of six key areas for improving outcomes for clients and staff: Health equity. Health inequity. Health disparities and social determinants. Health literacy. Cultural and linguistic literacy. Racial equity and social justice. (7/26/23) Beginning Your Journey: Essential Resources for New Prevention Practitioners A resource from the Great Lakes Prevention Technology Transfer Center (PTTC) This document was created to assist new substance misuse prevention practitioners in finding prevention resources to broaden their understanding of the prevention field. The resources compiled within this guide include links to the source content. (6/7/23) SAMHSA Advisory: Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns A resource from the Substance Abuse and Mental Health Services Administration This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy. It is critical that the general public be made aware of the potential harms associated with CBD use, and parents, in particular, should be advised to not let their children use non-FDA-approved CBD products. (2/23/23) 2022 Certified Community Behavioral Health Clinics Impact Report A resource from the National Council for Mental Wellbeing The Certified Community Behavioral Health Clinic (CCBHC) model is delivering the resources our nation needs to change the care landscape. CCBHCs are clinics –either certified by their states as CCBHCs or recipients of a federal CCBHC grant –that receive flexible funding to expand the scope of mental health and substance use services in their community. They serve anyone who walks through the door, regardless of ability to pay. Since 2017, the National Council for Mental Wellbeing has surveyed CCBHCs and grantees annually to glean insights into their activities and outcomes. This year’s report adds to our knowledge about the success of these clinics to expand access to care, hire and retain staff, and enable integrated care partnerships with federally qualified health centers (FQHCs), schools, hospitals, and law enforcement to help get people care when and where they need it –in effect, transforming how people access high-quality mental health and substance use care in America. (10/26/22) 2022-2026 NIDA Strategic Plan A resource from the National Institute on Drug Abuse (NIDA) This strategic plan reflects NIDA’s commitment to advancing all aspects of addiction science - from basic to translational, clinical, and health services research - in the service of enhancing fundamental knowledge and improving people’s lives. Priority Scientific Areas include 1) Understand Drug Use, Behavior, and the Brain; 2) Develop and Test Novel Prevention, Treatment, Harm Reduction, and Recovery Support Strategies; 3) Accelerate Research on the Intersection of Substance Use and HIV; 4) Study the Implementation of Evidence-Based Strategies in Real-World Settings; and 5) Translate Research into Innovative Health Applications. (10/14/22) Disrupting Stigma: How Understanding, Empathy, and Connection Can Improve Outcomes for Families Affected by Substance Use Disorders A resource from the National Center on Substance Abuse and Child Welfare This brief explains stigma specifically related to child abuse, neglect, and prenatal substance exposure. It describes structural stigma, public stigma, and self-stigma, details how stigma develops, reviews the history of substance use stigma in U.S. drug policies, and identifies the harmful effects of stigma. The brief then discusses rethinking responses and approaches and provides several strategies for fighting the stigma and facilitating engagement with parents and family members affected by substance use disorders. (9/12/22) Responding to the Current Youth Mental Health Crisis and Preventing the Next One Proceedings of a Workshop–in Brief A resource from the National Academies of Sciences, Engineering, and Medicine Across the country, mental health concerns are affecting children and youth in every community. Mental health providers are witnessing increased numbers of patients and increased severity in reported concerns. In the midst of this crisis, communities are exploring strategies for addressing children and youth's mental health, including increased investment in prevention. Given this current crisis, and the unprecedented response and potentially increased funding, there are opportunities to learn how to better incorporate prevention and promotion strategies into systems and programs for children and youth support. To explore these opportunities, the National Academies' Forum for Children's Well-Being held a 3-day workshop in May 2022. This Proceedings of a Workshop-in Brief provides a high-level summary of the topics addressed in the workshop. (8/30/22) Guidance, Actionable Steps, and Examples to Begin to Address Behavioral Health Care Disparities & Bring Racial Equity within the Behavioral Health Care System A Resource from the National Association of State Mental Health Program Directors (NASMHPD) Everyone should have an equitable (fair and just) opportunity to be as healthy as possible, no matter where they live, work, or play. To achieve this, we need to address social problems, unfair practices, and unjust conditions that can weaken the health of specific groups of Americans. NASMHPD’s Children, Youth, and Families Division has developed the following working document that provides suggested inward and outward-facing actionable steps, and examples as a guide for State Behavioral Health Agencies to address disparities and promote racial equity in the behavioral health care system. Under NASMHPD’s Transformation Transfer Initiative (TTI) program, we are promoting this resource and recognize that this document is a beginning guide. We invite new examples and strategies to be added as the behavioral health system and the larger health care system evolves. (7/7/22) Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition A resource from the American Journal of Psychiatry The authors present a newly developed National Institute on Alcohol Abuse and Alcoholism (NIAAA) definition of recovery from the DSM-5 diagnosis of alcohol use disorder (AUD). This definition views recovery as a process of behavioral change and an outcome, incorporating two key components of recovery: remission from DSM-5 AUD and cessation from heavy drinking, a non-abstinent recovery outcome. It also emphasizes the importance of biopsychosocial functioning and quality of life in enhancing outcomes. By adopting a uniform definition, researchers and health care professionals can more precisely operationalize and measure recovery-related processes. (5/24/22) Know Your Rights: Parity for Mental Health and Substance Use Disorder Benefits A Resource from the Substance Abuse and Mental Health Administration (SAMHSA) This is an updated trifold pamphlet explaining mental health parity, detailing what it means to the consumer, and listing the protections the parity law provides. It provides an overview of the Mental Health Parity and Addiction Equity Act of 2008 and lists some of the common limits placed on mental health and substance use disorder benefits and services. Read More (5/20/22) Stimulant Use Disorders and Behavioral Health Integration A resource from the Agency for Healthcare Research and Quality Academy (HRQA) The Academy has released a guide on stimulant use disorders and behavioral health integration that provides research evidence, guidance, and resources for treating stimulant use. in primary care practices. It can help practices support screening, assessment, treatment, management, and continuing care for stimulant use. The Academy has also added new tools and resources for treating stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s Helping People Who Use Opioids and Stimulants and the Substance Abuse and Mental Health Services Administration’s Treatment of Stimulant Use Disorders. Select for new tools and resources. (4/11/22) Substance Use Trend Alert 6 - Alcohol Consumption During the Pandemic in the U.S. and Florida A Resource from the Florida Alcohol and Drug Abuse Association and the Florida Department of Children and Families Substance Use Trend Alert 6 - Alcohol Consumption During the Pandemic in the U.S. and Florida A Resource from the Florida Alcohol and Drug Abuse Association and the Florida Department of Children and Families Alcohol consumption during the COVID-19 Pandemic increased compared to pre-pandemic years. Increased alcohol consumption could have been a coping mechanism for dealing with the stress of the pandemic. Several self-reported surveys indicated Americans increased their alcohol consumption during the pandemic. The short-term increases in alcohol consumption bring attention to long-term risks and emphasize the need for alternative approaches to managing stress. (3/22/22) Children’s Mental Health: Understanding an Ongoing Public Health Concern A resource from the Centers for Disease Control and Prevention (CDC) new Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC) documents the high prevalence of mental health disorders among America’s children even before the pandemic. Mental health encompasses a range of mental, emotional, social, and behavioral functioning and occurs along a continuum from good to poor. Previous research has documented that mental health among children and adolescents is associated with immediate and long-term physical health and chronic disease, health risk behaviors, social relationships, education, and employment. Public health surveillance of children’s mental health can be used to monitor trends in prevalence across populations, increase knowledge about demographic and geographic differences, and support decision-making about prevention and intervention. Numerous federal data systems collect data on various indicators of children’s mental health, particularly mental disorders. The 2013–2019 data from these data systems show that mental disorders begin in early childhood and affect children with a range of sociodemographic characteristics. (3/1/22) Lifesaving Addiction Treatment Out of Reach for Many Americans A state-by-state look at care provided by opioid treatment programs, a critical facility A resource from the Pew Charitable Trusts Drug overdose deaths skyrocketed during the COVID-19 pandemic: Provisional data covering a 12-month period shows that overdose deaths reached the record-setting number of more than 100,000 fatalities as of June 2021. Opioid treatment programs (OTPs)—the only health care facilities that can offer patients all three forms of medication for opioid use disorder (OUD): methadone, buprenorphine, and injectable extended-release naltrexone—are critical to reducing overdose deaths and providing life-saving addiction treatment. But they do so only if patients are able to access services. Results from a new study by The Pew Charitable Trusts show that geography and health insurance coverage, rather than medical need, often determine whether patients can access effective treatment for OUD. Pew’s 50-state analysis of OTPs found significant disparities in care from state to state. (2/22/22) Psychosocial Interventions for Older Adults With Serious Mental Illness A resource from the Substance Abuse and Mental Health Services Administration The guide provides considerations and strategies for interdisciplinary teams, peer specialists, clinicians, registered nurses, behavioral health organizations, and policy makers in understanding, selecting, and implementing evidence-based interventions that support older adults with serious mental illness. (11/18/21) Treatment Improvement Protocol (TIP) 33: Treatment for Stimulant Use Disorders A resource from the Substance Abuse and Mental Health Services Administration This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence. (11/18/21) Treating Concurrent Substance Use Among Adults A resource from the Substance Abuse and Mental Health Services Administration This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD). (10/6/21) Medicaid Forward Behavioral Health By the National Association of Medicaid Directors This framework, crafted by an Executive Working Group of Medicaid leaders and national behavioral health experts convened by the National Association of Medicaid Directors, offers states options to consider to promote the health and wellbeing of members and expand access to behavioral health services. It includes strategies along a continuum of need, ranging from upstream prevention and health promotion for all Medicaid beneficiaries to increasing access to behavioral health treatment for unique subpopulations in Medicaid. (3/4/21) Behavioral Health Workforce Report SAMHSA’s mission is to reduce the impact of mental illness and substance misuse on America’s communities, ensuring that individuals with mental and SUDs have access to evidence-based high-quality care. A major factor in achieving this goal is addressing the training and education needs of practitioners. To facilitate the achievement of this goal, data on the current numbers and trends within practitioner fields is imperative. The goal of this report is to provide information on evidence-based models of care for those with serious mental illness and substance use disorders, practitioner numbers needed to meet the behavioral health needs of the American people, and to offer a foundation on which a model for a mental health system that will address these needs can be established. (12/22/20) Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder Medications for opioid use disorder, including buprenorphine hydrochloride and methadone hydrochloride, are highly effective at improving outcomes for individuals with the disorder. For pregnant women, use of these medications also improves pregnancy outcomes, including the risk of preterm birth. In this cross-sectional study with random assignment of clinicians and simulated-patient callers, many women, especially pregnant women, faced barriers to accessing treatment. Given the high out-of-pocket costs and lack of acceptance of insurance among many clinicians, access to affordable opioid use disorder treatment is a significant concern. (8/21/20) Obstetric Delivery Inpatient Stays Involving Substance Use Disorders and Related Clinical Outcomes, 2016 Agency for Healthcare Research and Quality, Statistical Brief #254 This Healthcare Cost and Utilization Project (HCUP) Statistical Brief presents statistics from the 2016 National Inpatient Sample (NIS) on delivery-related inpatient stays involving SUDs, overall and for select types of substances: opioids, cocaine, and other stimulants, as well as for both urban and rural areas. The definition of any substance use does not include tobacco use. Clinical outcomes at delivery are examined and compared across deliveries with and without an SUD diagnosis and by urban or rural location of the patient's residence. (11/13/19) Mental and Substance Use Disorder Treatment for People With Physical and Cognitive Disabilities This Advisory highlights how mental and substance use disorder treatment programs can better serve people with physical and cognitive disabilities and substance use disorders (SUDs) and/or serious mental illness (SMI). The most current prevalence data (2016), indicates that an estimated 61.4 million noninstitutionalized U.S. adults had one or more disabilities.1 SMI and co-occurring substance use disorder SUDs are generally considered disabilities under federal disability rights laws. This publication is not intended to provide guidance on complying with federal, state, or local disability rights laws. This advisory includes some recommendations that are required, may be required or may exceed the requirements of the federal, state, or local disability rights laws. (9/18/19) New Evidence-Based Practices Resource Center SAMHSA's new Resource Center contains a collection of science-based resources for a broad range of audiences, including Treatment Improvement Protocols, toolkits, resource guides, and clinical practice guidelines. Recognizing the enormity of the opioid epidemic, the Resource Center includes an opioid-specific resources section. Characteristics of Inpatient Stays Involving Hepatitis C, 2005-2014 (11/17 AHRQ) Hospital stays involving hepatitis C increased 67 percent among Baby Boomer patients more than any other age group, according to a new AHRQ brief. Hospital stays involving hepatitis C nearly tripled likely due to increased needle use associated with the nation's opioid epidemic. Access the brief and visit Webinars to see our latest training on Infectious Disease Control for Persons Who Inject Drugs with Dr. Cook. 2017 Florida Best Practice Recommendations for Women of Reproductive Age with Serious Mental Illness and Comorbid Substance Use Disorders This publication provides guidance to clinicians who treat women that are pregnant or of childbearing age with substance use problems. Developed by the University of South Florida, Florida Medicaid Drug Therapy Management Program, and sponsored by the Florida Agency for Health Care Administration, the recommendations also address use of long-acting contraceptives in women of childbearing age MAT Guide to Long-acting Medications A resource from the National Council for Mental Wellbeing Drawing upon clinical guidance from the American Association of Community Psychiatrists and research from the National Institute for Mental Health, this guide emphasizes the importance of long-acting medications (LAMs) in treating psychotic disorders, bipolar disorder, opioid use disorder (OUD) and alcohol use disorder (AUD). The guide urges all community mental health and substance use treatment clinicians to provide LAMs as a first-line treatment option. It highlights the need for organizations to establish systems to educate staff, patients and families about the safe and effective use of LAMs. Additionally, it recommends implementing continuous quality improvement processes that lead to enhanced patient understanding and access to LAMs. (04/01/2025) Federal Guidelines for Opioid Treatment Programs A resource from the Substance Abuse and Mental Health Services Administration SAMHSA’s new 2024 Federal Guidelines for Opioid Treatment Programs (OTP) provide recommendations, guidance, and best practices for opioid treatment programs (OTPs) on the implementation and compliance of regulation changes in 42 CFR Part 8, effective April 2, 2024. This manual provides updated guidelines for operating an opioid treatment program. It covers patient-centered care planning, assessment, admission, and monitoring; medication administration and use; medical and clinical provisions and practices; certification and accreditation; and the importance of practitioner judgment in providing care. (12/5/2024) 42 CFR Part 8 Regulation Video Series - Snapshots for Implementation A resource from the Substance Abuse and Mental Health Services Administration SAMHSA has produced a video series to highlight key changes to 42 CFR Part 8, the regulations that set standards for care provided by opioid treatment programs (OTPs). The video series provides an overview of the first major regulatory updates in more than two decades, the heart of which is a fundamental shift to treat opioid use disorder (OUD) as a chronic health issue, focusing on patient-centered care, grounded in shared decision-making between individuals and their health care providers. This shift is embodied in several key changes that expand access to care, enhance the workforce encourage collaboration, and remove barriers to treatment, including allowing the use of telehealth for some aspects of care, reducing admission requirements, and incorporating flexibility for take-home medication. (12/5/2024) Issue Brief: Co-Occurring Mental Health and Substance Use A resource from the Substance Abuse and Mental Health Services Administration This Issue Brief offers valuable information to State Mental Health Authorities (SMHA) about co-occurring mental health and substance use disorders (COD). The document highlights the commonality of CODs and negative outcomes in the absence of evidence-based integrated care. It also provides an overview of treatment barriers and potential solutions, and the effectiveness of integrated care. This Issue Brief is one in a series of briefs created by SAMHSA to provide guidance to State Mental Health Agencies to support improvement of the mental health systems within their states. (12/3/2024) Use of High-Dose Buprenorphine for the Treatment of Opioid Use Disorder Listening Session Report A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) On December 11, 2023, SAMHSA, in partnership with the U.S. Food and Drug Administration and the National Institute on Drug Abuse, hosted a listening session to discuss the medical need, emerging data, and barriers to accessing higher doses of buprenorphine in the context of high potency synthetic opioid (HPSO) exposure. Over 200 individuals representing a wide range of disciplines related to OUD services, including providers, academics, researchers, and those with lived experience. This report provides important insights into the effectiveness of high-dose buprenorphine for treating opioid use disorder, especially among individuals exposed to high-potency synthetic opioids. (10/23/2024) New Report: Medicaid Coverage of Medications to Reverse Opioid Overdose and Treat Alcohol and Opioid Use Disorders A resource from SAMHSA SAMHSA is releasing a new report Medicaid Coverage of Medications to Reverse Opioid Overdose and Treat Alcohol and Opioid Use Disorders to improve behavioral health care by understanding the financing of behavioral health care to identify opportunities and challenges to service delivery and access to care. The report will discuss the availability of, and access to, medications for treating ongoing alcohol use disorder (AUD) and opioid use disorder (OUD) and reversing an opioid overdose within state Medicaid plan. The report provides an update on the present state of coverage and availability of these treatments to Medicaid beneficiaries. It also includes examples of innovative efforts to increase access to medications for the treatment of SUDs. This work builds on two prior SAMHSA reports - Medicaid Coverage of Medication-Assisted Treatment for Alcohol and Opioid Use Disorders and of Medication for the Reversal of Opioid Overdose (2018) and Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Use Disorders (2014). (02/01/2024) 15 Key Buprenorphine Dosing Recommendations for Jail-Based Treatment Programs A resource from the Justice Community Opioid Innovation Network (JCOIN) JCOIN researchers Drs. Elizabeth Evans, Ekaterina Pivovarova, Thomas Stopka, Claudia Santelices, Warren Ferguson, and Peter Friedmann from the University of Massachusetts Amherst, the University of Massachusetts Chan Medical School, Baystate Health, and Tufts University outline key steps MOUD program treatment staff can implement in order to prevent diversion and provide guidance to corrections and lawmakers as they consider establishing and expanding MOUD treatment in correctional settings. Recommended protocols span the entire MOUD dispensing cycle: from dispensing preparation and process to supervision following medication initiation and ensuring proper consumption to handling suspected diversion. Access the infographic of the 15 Key Buprenorphine Dosing Recommendations for Jail-Based Treatment Programs here. (12/11/2023) Improving Buprenorphine Access in Pharmacy Settings Policy Priority Roundtable Summary Report A resource from SAMHSA In August 2022, SAMHSA convened a Policy Priority Roundtable with pharmacy organizations, state health departments, nonprofit associations, academic institutions, and people with lived experiences. where pharmacy organizations called for an opportunity to engage directly with federal agencies about challenges affecting buprenorphine supply. (12/07/2023) Opioid-Overdose Reduction Continuum of Care Approach (ORCCA): A Policymakers Guide to Implementing Evidence-Based Strategies that Address Opioid Overdose A resource from the Addiction Policy Forum The HEALing Communities Initiative, the National Institute on Drug Abuse (NIDA) and the NIH Helping to End Addiction Long-term (HEAL) Initiative® today launched the Opioid-Overdose Reduction Continuum of Care Approach (ORCCA): A Policymakers Guide to Implementing Evidence-Based Strategies that Address Opioid Overdose. The guide was created to aid policymakers, communities, and key stakeholders in developing comprehensive, multi-system strategies that address the opioid crisis. The science and evidence behind the framework was published in the Journal of Drug and Alcohol Dependence and outlines 19 essential evidence-based interventions to reduce opioid overdose deaths. (12/05/2023) National trends of suicidal ideation and mental health services use among US adults with opioid use disorder, 2009–2020 A resource from eClinicalMedicine, Part of The Lancet Discovery Science National Survey on Drug Use and Health (NSDUH) data were used to examine trends in suicidal ideation (SI) between 2009 and 2020 among adults aged 18 or older with OUD. From 2009 to 2020, the prevalence of individuals with OUD who reported SI increased significantly from 22.8% to 29.8%. The subgroups with the most significant changes included young adults, females, non-Hispanic whites, working full-time, individuals with Medicaid, living in a large metropolitan areas, and having another SUD. Among those with past-year OUD, over half with SI reported needing mental health treatment in the past year but not receiving it. (10/26/22) Substance Use Trend Alert 5 - Gabapentin Use in the U.S. and Florida A Resource from the Florida Alcohol and Drug Abuse Association and the Florida Department of Children and Families Gabapentin is used to prevent seizures and relieve pain for certain conditions. Gabapentin, combined with other drugs that suppress the central nervous system like opioids, has been shown to increase the risk of mortality. The misuse of gabapentin during the rise of the opioid epidemic has raised concern about this drug. In 2020, the Florida Medical Examiner's Commission reported a total of 861 occurrences of gabapentin-related deaths. (3/16/22) Interactive Map on State Harm Reduction Strategies A resource from the Association of Maternal & Child Health Programs and NASADAD The Association of Maternal & Child Health Programs (AMCHP), in conjunction with the National Association of State Alcohol and Drug Abuse Directors (NASADAD), has released an interactive collection of case studies on state harm reduction strategies. This interactive map and case studies highlight successful collaborations between state MCH programs and substance use disorder agencies, identify examples of evidence-based harm reduction practices at the state and local level, and share key takeaways of these practices. (12/15/21) Medications for Opioid Use Disorder Infographic A resource from the National Institute on Drug Abuse This infographic shows the different types of medications prescribed for opioid overdose, withdrawal, and addiction. (9/17/21) Los medicamentos para la sobredosis, la abstinencia y la adicción a los opioides Un recurso del National Institute on Drug Abuse Esta infografía ilustra los distintos tipos de medicamentos que se recetan para la sobredosis, la abstinencia y la adicción a los opioides.Esta infografía ilustra los distintos tipos de medicamentos que se recetan para la sobredosis, la abstinencia y la adicción a los opioides. (9/17/21) Updated TIP 63: Medications for Opioid Use Disorder A resource from the Substance Abuse and Mental Health Services Administration This updated version of Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder reviews the use of the three Food and Drug Administration-approved medications used to treat Opioid Use Disorder (OUD)—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support recovery for people with OUD. Updates include: Additional information about the qualifications of practitioners who are eligible to apply for a waiver to prescribe buprenorphine (i.e., clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives) that explains exceptions under the latest buprenorphine practice guidelines on obtaining a waiver. Citations that support induction onto extended-release naltrexone of people with positive urine tests for opioids so long as they pass the naloxone challenge. Clarification that naltrexone can result in decreased opioid cravings. Where needed, clarification of whether discussion about naltrexone refers to the oral formulation or the extended-release injectable formulation. Updated statistics on opioid-related deaths, overdoses, accidents, and hospitalizations. Updated online resources. (8/4/21) Stimulant Deaths on the Rise, Compounded by Rise in Synthetic Opioids This interactive graphic series allows users to explore data trends related to the rapid rise in overdose deaths involving stimulants. Stimulants are drugs that speed up the body’s systems. This category of drugs comprises prescription amphetamines (including methamphetamine) used to treat ADHD, narcolepsy and obesity as well as illicitly-manufactured cocaine and methamphetamine. Prescription amphetamines come in pill form intended for slow release, but may be abused by crushing the pills into a powder that can be injected or inhaled for a very quick effect. Illicit methamphetamine and cocaine can also be in a powder form or in crystal form that can be smoked (i.e., crystal meth and crack cocaine). (6/4/21) Substance Use among Lesbian, Gay, and Bisexual (LGB) Youth in the U.S. and Florida Substance use affects those who identify as lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ) at higher rates than their heterosexual counterparts. Little is known about the risk for substance use in LGBTQ adolescents, however, existing survey data suggests significant differences in substance use prevalence rates between U.S. and Florida high school students who identify as lesbian, gay, and/or bisexual and their heterosexual counterparts. (5/18/21) Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder A Notice by the Health and Human Services Department on 04/28/2021 The Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder provides eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services (i.e., psychosocial services). (5/6/21) Use of Medication-Assisted Treatment in Emergency Departments By the Substance Abuse & Mental Health Services Administration This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation. (3/1/21) Caring for Women with Opioid Use Disorder: A Toolkit for Organization Leaders and Providers Women are uniquely impacted by opioid use: women who use opioids progress to dependence more quickly than men, experience more cravings, and are more likely to relapse. The toolkit developed by the HRSA Office of Women's Health, with support from the HHS Office on Women's Health, provides resources and information to bolster care coordination services for women with opioid use disorder. (12/22/20) The American Opioid Epidemic in Special Populations: Five Examples Although the crisis has affected large swaths of the U.S. population, it has affected certain segments of the population with an extra level of intensity—justice-involved populations, rural populations, veterans, adolescents and young adults, and persons who inject drugs. For each identified population, this manuscript reviews why it is an important area of focus, current barriers encountered in accessing care, promising approaches in supporting this population, and high-impact research and action priorities. (10/29/20) La crisis de los opioides en la población Hispana/Latina: un asunto urgente The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue (Spanish version) La crisis de los opioides no ha disminuido y ha tenido un impacto significativo en las comunidades hispanas / latinas en los EE. UU. Este resumen presenta datos recientes sobre la prevalencia del uso indebido de opioides y las tasas de mortalidad en la población hispana / latina; factores contextuales y desafíos para la prevención y el tratamiento; estrategias innovadoras de divulgación y participación para conectar a las personas con un tratamiento basado en la evidencia; y la importancia de la voz de la comunidad. (10/16/20) Access the English version here: https://store.samhsa.gov/product/The-Opioid-Crisis-and-the-Hispanic-Latino-Population-An-Urgent-Issue/PEP20-05-02-002 Models for Medication-Assisted Treatment for Opioid Use Disorder, Retention, and Continuity of Care The Office of Disability, Aging, and Long-Term Care Policy (DALTCP), within the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Planning and Evaluation (ASPE), recently published a report regarding medication-assisted treatment (MAT), treatment retention, and continuity of care. The report compiled results from a three-part study that included a literature review, informant interviews, and five case studies that showed improved retention in treatment. As described in the report, researchers concluded that many variables affect retention in substance use disorder (SUD) treatment and it is the interaction of those variables that is critical – whether they are client characteristics, provider or service delivery characteristics, setting-based factors, or external variables such as cross-system collaboration or payment policies. Results of the study were categorized into four sections: client characteristics, evidence or practice-based approaches to addressing retention, psychosocial supports, and reimbursement approaches. (7/27/20) Drug-related Death Leading Cause of Pregnancy-associated Death in Florida While Florida’s overall Pregnancy Associated Deaths (PAD) declined in the past decade, drug-related PAD nearly doubled from 9.5 to 17.9 per 100,000 live births. In 2017, the leading cause of PAD in Florida was related to drug use, occurring at least twice as often as any other cause. Maternal health plays a fundamental role in infant health and well-being. The recent increase in substance use during pregnancy negatively impacts fetuses, infants, and women, contributing to a myriad of negative health issues, including death. Education, screening, testing, and treatment play an important role in decreasing negative health issues and pregnancy-associated deaths. This Alert includes helpful resources and research relating to pregnant women and substance use. (7/27/20) Updated TIP 63: Medications for Opioid Use Disorder A resource from the Substance Abuse and Mental Health Services Administration This updated version of Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorder reviews the use of the three Food and Drug Administration-approved medications used to treat Opioid Use Disorder (OUD)—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support recovery for people with OUD. Updates include: Additional information about the qualifications of practitioners who are eligible to apply for a waiver to prescribe buprenorphine (i.e., clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives) that explains exceptions under the latest buprenorphine practice guidelines on obtaining a waiver. Citations that support induction onto extended-release naltrexone of people with positive urine tests for opioids so long as they pass the naloxone challenge. Clarification that naltrexone can result in decreased opioid cravings. Where needed, clarification of whether discussion about naltrexone refers to the oral formulation or the extended-release injectable formulation. Updated statistics on opioid-related deaths, overdoses, accidents, and hospitalizations. Updated online resources. (8/4/21) The Opioid Crisis and the Black/African American Population: An Urgent Issue An issue brief from SAMHSA’s Office of Behavioral Health Equity. The opioid crisis has not abated and has had a significant impact on African American communities. This issue brief presents recent data on prevalence of opioid misuse and death rates in the Black/ African American population; contextual factors and challenges to prevention and treatment; innovative outreach and engagement strategies to connect people to evidence-based treatment; and the importance of community voice. (5/1/20) The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. The document is an update to the previous NPG released in 2015 and includes major revisions to 35 existing recommendations, along with the addition of 13 new recommendations. This focused update was developed over the course of 14 months with consensus from an independent committee of experts and the use of a rigorous RAND/RAM methodology facilitated by researchers from Research Triangle Institute (RTI). (4/1/20) TIP 63: Medications for Opioid Use Disorders (SAMHSA - Revised 5/2019) This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. (6/14/19) Medicaid Coverage of Medication-Assisted Treatment for Alcohol and Opioid Use Disorders and of Medication for the Reversal of Opioid Overdose The report discusses Medicaid coverage of FDA-approved medications for treatment of alcohol and opioid use disorders, limitations on coverage (such as prior authorization requirements), background on federal laws and policies and innovative practices and policies at the state level. (1/4/19) Statewide Drug Policy Advisory Council 2018 Annual Report The Statewide Drug Policy Advisory Council presents its 2018 Annual Report which is a compilation of information from the members of the Council. (1/3/19) Medication-Assisted Treatment Fact Sheets These NIATx fact sheets provide easy access to information on using FDA-approved medications as part of a comprehensive treatment plan for substance use disorders. Recovery Addressing Burnout in the Behavioral Health Workforce through Organizational Strategies A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) Addressing Burnout in the Behavioral Health Workforce through Organizational Strategies A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) Burnout is a complex issue resulting from chronic workplace stress that encompasses exhaustion, depersonalization, and reduced personal accomplishment. This guide will highlight organization-level interventions to prevent and reduce burnout among behavioral health workers. (05/09/2024) Best Practices for Recovery Housing A resource by SAMHSA This document updates a prior Recovery Housing Guideline and now outlines best practices for the implementation and operation of recovery housing that is intended to serve as a tool for states, governing bodies, providers, recovery house operators and other interested stakeholders to improve the quality of housing programs, protect residents’ rights, reduce incidence of overdose, and promote long-term recovery from substance use and co-occurring disorders. (9/01/2023) National Model Standards for Peer Support Certifications A resource from SAMHSA On June 6th, the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), published National Model Standards for Peer Support Certification for substance use, mental health, and family peer workers. The national model standards were created to accelerate universal adoption, recognition, and integration of the peer workforce across all elements of the healthcare system. (9/27/23) Modelo nacional de normas para la certificación de apoyo entre pares Recursos provehido por SAMHSA El documento guía de modelo de normas de SAMHSA titulado, Modelo nacional de normas para la certificación de apoyo entre pares, ha sido preparado como respuesta a la agenda de unidad del 2022 del presidente Biden. Este documento delinea el modelo nacional de normas en el área del consumo de sustancias, la salud mental la familia así como también la certificación de apoyo entre pares jóvenes. (9/27/23) Recovery Summit Executive Summary A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) SAMHSA has posted an Executive Summary of the August 2022 Recovery Now! Summit that the agency hosted for 200 in-person and virtual participants to collaborate on the Office of Recovery’s National Recovery Agenda. Representatives included persons with lived experience of mental health or substance use challenges and recovery, substance use preventionists, harm reductionists, treatment and recovery support providers, researchers, staff of federal and state partners, and other allies. (4/26/23) Law Enforcement & Corrections National Guidance on Essential Specialty Substance Use Disorder Care A resource from the Substance Abuse and Mental Health Services Administration’s (SAMHSA) This guidance articulates a core or essential set of services for adults with SUD that should be available at any specialty SUD treatment facility in the United States. The intended audiences are states and payers, accreditation entities, adults and families in need of care, specialty SUD treatment facility operators/administrators, behavioral health professionals, researchers, and local governments. Currently, there is a dramatic lack of consistency in services available to adults in need of specialty SUD treatment. The goal of this guidance is for the intended audiences to use this tool to identify treatment gaps, support evidence-based planning, and improve outcomes for adults with SUD. (2/5/2024) 2024 Drugs of Abuse A resource from the Drug Enforcement Administration (DEA), U.S. Department of Justice Education plays a critical role in preventing substance use and misuse. Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly used and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts. Drugs of Abuse also offers a list of additional drug education and prevention resources. 2024 Drogas de Abuso Un recurso de la Drug Enforcement Administration (DEA), U.S. Department of Justice La educación juega un papel esencial en la prevención del uso y el uso indebido de sustancias. Drogas de abuso, Una guía de recursos de la DEA está diseñada para ser una fuente confiable de información sobre las drogas de uso más común y uso indebido en Estados Unidos. Esta guía completa proporciona información importante sobre los daños y las consecuencias del uso de drogas al describir los efectos en el cuerpo y la mente de una droga, su potencial de sobredosis, origen, situación legal y otros datos clave. Drogas de Abuso también ofrece una lista de recursos adicionales para la educación y prevención sobre drogas. (01/07/2025) Implementing Evidence-Based Strategies to Reduce Overdose Risk during Reentry: A Primer for Reentry Professionals A resource from the Council of State Governments Justice Center and the Addiction Policy Forum Too often, people reentering the community from incarceration experience fatal overdoses, with studies showing that they are at a highest risk of an overdose or even death during the first 48 hours after release. This is typically related to a decrease in tolerance while in prison or jail, so their body is more vulnerable to overdosing even when using at the same amount they did before they were incarcerated. This risk is highest among people using opioids. Fortunately, there are evidence-based practices that can be implemented to support safe and successful transitions. This guide outlines four best practices that reentry professionals can implement to reduce overdose risk during reentry. (10/21/2024) Understanding Overdose Risk for People Reentering the Community: An Informational Guide for Families A resource from the Council of State Governments Justice Center and the Addiction Policy Forum Reentry, in general, can be a challenging time for people as they are preparing to transition back into the community. For people with a substance use disorder, reentry is even more challenging because of the potential to relapse and experience overdose. Studies show that family support can improve outcomes for a person in treatment, however, and is a significant factor in predicting long-term recovery. This guide outlines ways to support a family member or loved one and evidence-based strategies for achieving recovery, including tips for families who want to support these efforts. (10/21/2024) Trend Alert - Delta-8 THC in the U.S. and Florida A resource from FADAA and the Florida Department of Children and Families Delta-8 THC products are currently being sold online, in gas stations, and convenience stores although these products have not been approved by the Food and Drug Administration for safe use. They are marketed in ways that put public health at risk. Serious symptoms include seizures, comas, and sedation. The rise in exposures to Delta-THC showcases the importance of safe storage and packaging. (10/18/2024) SAMHSA’s Practitioner Training A resource from the Substance Abuse and Mental Health Services Administration SAMHSA's practitioner training offers tools, training, and technical assistance to practitioners in the fields of mental health and substance use disorders. (03/14/2024) Trend Alert – Naloxone Administration in the U.S. and Florida A resource by FADAA and the Florida Department of Children and Families Naloxone is a medication used to reverse an opioid overdose. Studies show that naloxone distribution programs among emergency personnel and anyone in a position to save the life of someone at risk of an opioid overdose can prevent 21% of opioid overdose deaths. Data indicates that naloxone administration has increased across the nation and in Florida. Evidence-based strategies for preventing opioid overdoses include naloxone distribution programs and to educate and train individuals to potentially save lives." (03/13/2024) 2023 Patterns of and Trends in Substance Use in Florida Annual Report UPDATE A resource by FADAA and the Florida Department of Children and Families The 2023 Annual Update Report provides new information about substance use among youth and adults across Florida. It examines trends in recent behavioral health data to help guide Florida’s substance use prevention and treatment efforts. Data for this update was obtained from a diverse number of sources including the 2021 National Survey on Drug Use and Health (NSDUH), the 2023 Florida Youth Substance Abuse Survey (FYSAS), the Florida Department of Health Opioid Use Dashboard, and the Drugs Identified in Deceased Persons by the Florida Medical Examiners 2021 Annual Report (December 2022). (02/26/2024) Underlying Causes of MOUD Diversion in Jails: Strategies and Solutions A resource from Policy Research Associates Medications for opioid use disorder (MOUD) are the leading evidence-based treatment for opioid use disorder (OUD). Abundant research shows that MOUD reduces the risk of recurrence of opioid use, involvement with the justice system, and death, both in the community and in jails. While many jails nationwide have started to offer MOUD, there are others that are not ready or able to take that step. One concern is the possibility of medication diversion. Recent research indicates that concerns about MOUD diversion in jail may be assuaged with some proven strategies. (4/26/23) Public Safety-led Community-oriented Overdose Prevention Efforts (PS-COPE) A resource from the National Council for Mental Wellbeing This toolkit which introduces a revolutionary framework that public safety agency leaders and administrators can use to enhance overdose prevention and response in the Black, Indigenous and people of color (BIPOC) communities they serve. is a new approach to overdose prevention and response for Black, Indigenous and people of color (BIPOC) communities. It combines three proven models to enhance overdose prevention and response: trauma-informed care, recovery-oriented systems of care and procedural justice. The interactive toolkit provides tips, implementation tools and resources to help integrate the approach into existing overdose prevention and response efforts. The accompanying concept paper provides more details and describes how public safety agencies — and the communities they serve — will benefit from adopting this new approach. The purpose of this toolkit is to: Define the principles and core elements of PS-COPE. Describe how public safety agencies — and the communities they serve — will benefit from adopting this approach. Provide tools for integrating the approach into existing overdose prevention and response efforts. (2/7/23) The Essential Aspects of Parity: A Training Tool for Policymakers A Resource from the Substance Abuse and Mental Health Administration (SAMHSA) The Essential Aspects of Parity: A Training Tool for Policymakers This document provides state regulators and behavioral health staff an overview of mental health and substance use disorder parity and how to implement and comply with the federal parity law regarding employee-sponsored health plans and group and individual health insurance. This guide applies to parity laws in employer-sponsored health plans and group and individual insurance. Read More (5/20/22) First Responders and Disaster Responders Resource Portal A resource from the Substance Abuse and Mental Health Services Administration (SAMHSA) This SAMHSA Disaster Technical Assistance Center (DTAC) portal was developed with first responders and disaster responders in mind to help them learn about the signs of stress and how to better manage it. With knowledge of risk factors and using healthy coping strategies, responders can further build their personal resilience. This page has a variety of online trainings and resources for responders in both English and Spanish. (3/3/22) Drug Arrests Stayed High Even as Imprisonment Fell From 2009 to 2019 A resource from the Pew Charitable Trusts To better identify and understand recent changes in and effects of the use of the criminal legal system to address drug problems, The Pew Charitable Trusts analyzed publicly available national data on drug arrests and imprisonment, drug treatment, and harm from drug misuse from 2009 through 2019—the most recent decade for which data is available. The study found divergent enforcement trends—high rates of arrest but substantially reduced incarceration—coupled with a lack of treatment options and high mortality rates among people with illicit drug dependence. (2/23/22) Deflection and Pre-arrest Diversion to Prevent Opioid Overdose A resource from the National Council for Mental Wellbeing People involved with the criminal justice system – especially those with substance use disorders (SUDs) – encounter barriers to and delays in receiving evidence-based treatment; increased risks of overdose and death, especially immediately after release from incarceration; and barriers to employment, housing and financial stability that create significant hurdles to achieving and sustaining recovery. Communities across the country have implemented deflection and pre-arrest diversion (DPAD) initiatives to link people who use drugs to evidence-based care and services instead of incarceration. The National Council for Mental Wellbeing, with support from the Centers for Disease Control and Prevention (CDC), developed a package of resources to support the adoption and implementation of DPAD programs to better support people at risk of opioid overdose. These resources were informed by real-world experiences shared through a series of key informant interviews and an Experts’ Roundtable with diverse stakeholders implementing DPAD programs across the country. (11/18/21) Training and Educating Public Safety to Prevent Overdose Among Black, Indigenous, and People of Color Communities A resource from the National Council for Mental Wellbeing Individuals, communities, and health care systems across the country are struggling to cope with the ongoing overdose epidemic, which is having a disproportionate impact on communities of color. In 2020, drug overdose deaths rose 29.4%, including 69,710 deaths involving opioids. Public safety personnel (police, law enforcement, firefighters, paramedics, and emergency medical technicians) are often the first on the scene for overdose emergencies; however, the skills required to respond to these situations are not acquired through traditional public safety trainings. To identify the extent of public safety-led overdose prevention efforts and corollary training for public safety personnel that are tailored for Black, Indigenous, and people of color (BIPOC) communities, the National Council for Mental Wellbeing, with support from the Centers for Disease Control and Prevention (CDC), conducted an environmental scan consisting of a literature review, 11 key informant interviews, and two roundtable discussions with a diverse group of individuals with experience in overdose prevention, harm reduction, or public safety. (10/19/21) Synthetic Opioids Driving a Worsening Crisis of Overdose Deaths These interactive graphics allow users to explore how the crisis of overdose deaths involving opioid use has not only grown in magnitude since 2000, but has also changed in character. (6/4/21) TAP 34: Disaster Planning Handbook for Behavioral Health Service Programs This Technical Assistance Publication (TAP), updated in 2021, provides guidance for behavioral health service and substance use disorder treatment programs wanting to develop or update a comprehensive, scalable, and flexible disaster plan. It addresses planning needs specific to programs that offer prevention services, outpatient or residential treatment, medically supervised withdrawal, and pharmacotherapy (4/15/21) Overdose Deaths Escalate during COVID-19 Pandemic The COVID-19 pandemic may have had unintended consequences for substance use and overdoses in the United States. Although overdose deaths were increasing before COVID-19, the latest data suggest overdose deaths have escalated during the pandemic. Based on CDC estimates, over 81,000 overdose deaths occurred in the United States in the 12 months ending in May 2020. This is the highest number of overdose deaths recorded within a 12-month period. Florida had a 38.4% increase in estimated drug overdose deaths from July 2019 to July 2020 compared to an estimated 24.2% increase nationally. (3/9/21) After Incarceration: A Guide To Helping Women Reenter the Community This guide from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides individuals who provide or coordinate reentry services for women involved in the CJ system with resources for serving women who are reentering the community after a period of incarceration. It is a "checklist " of considerations when working with women who are justice involved. (5/1/20) Drugs of Abuse: A DEA Resource Guide. 2020 Edition This guide is designed to be a reliable resource on the most commonly used and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, legal status, and other key facts. The publication also offers a list of drug education and prevention resources. (4/15/20) Fentanyl Flow to the United States A report from the US Drug Enforcement Administration The flow of fentanyl into the United States in 2019 is more diverse compared to the start of the fentanyl crisis in 2014, with new source countries and new transit countries emerging as significant trafficking nodes. This is exacerbating the already multi-faceted fentanyl crisis by introducing additional source countries into the global supply chain of fentanyl, fentanyl-related substances, and fentanyl precursors. (4/1/20 Lethal Means & Suicide Prevention: A Guide for Community & Industry Leaders A product of the National Action Alliance for Suicide Prevention The report describes the role of reducing access to lethal means among those who may be at risk for suicide, and highlights actions being taken by governments, organizations, and industries that have resulted in lives being saved. The purpose of the report is to help community and industry leaders take lifesaving action that helps put time and distance between a lethal means and individuals who may be at risk for suicide. (3/24/20) Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons A Planning & Implementation Toolkit This toolkit provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatment (MAT) in correctional settings and strategies for overcoming challenges. Informed by real-world practice, the toolkit provides examples from the field that can be widely applied and adapted. Some of the tools and resources found in the toolkit include: Screening and assessment tools. Strategies to reduce medication diversion. Flowchart on how to become an opioid treatment program. List of no-cost training resources. Sample forms, policies and operating procedures and monitoring and evaluation metrics. (2/5/20) 2018 State Report on Underage Drinking Prevention and Enforcement 2018 State Report on Underage Drinking Prevention and Enforcement The 2018 Florida State Report on Underage Drinking Prevention and Enforcement, prepared by the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) as required by the Sober Truth on Preventing (STOP) Underage Drinking Act is now available. This report describes 26 evidence-based legal policies for underage drinking prevention (Policy Summaries), summarizes and analyzes data on state prevention and enforcement activities and expenditures, and shows state performance on six underage drinking prevention and treatment measures. A slide presentation that includes key data from the State Report and comparisons with national data is available here. The presentation is intended to be customized by users to provide information to specific audiences about the importance of addressing underage drinking in Florida. (7/31/19) ONDCP releases National Drug Control Strategy The White House Office of National Drug Control Policy (ONDCP), led by Director Jim Carroll, released its National Drug Control Strategy. The Strategy is intended to guide federal efforts with three overarching categories: 1) preventing illicit drug use through education and evidence-based prevention programs; 2) reducing barriers to treatment services so that access to long-term recovery is available for those suffering from substance use disorder; and 3) reducing the availability of drugs in the United States through law enforcement and cooperation with international partners. (2/11/19) Drugs of Abuse: A DEA Resource Guide Education plays a critical role in preventing substance abuse. Drugs of Abuse, A DEA Resource Guide, is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. This comprehensive guide provides important information about the harms and consequences of drug use by describing a drug’s effects on the body and mind, overdose potential, origin, legal status, and other key facts. (May 2018) Substance Abuse Trends Alert: Recent International Actions to Control Deadly Fentanyl Analogs Recent International Actions to Control Deadly Fentanyl Analogs (FADAA Substance Abuse Trends Alert, 1/18). International cooperation has led to new approaches designed to staunch the flow of fentanyl analogs into the United States. Drugs Identified in Deceased Persons by Florida Medical Examiners (FDLE, 11/17) The Medical Examiners Commission recently produced their annual report that identifies drugs found in deceased persons investigated by Florida Medical Examiners. The data distinguishes between drugs indicated as the cause of death and other drugs that were present in the body at the time of death. Data was collected on Opioids, Benzodiazepines, and other drug categories.
